Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting
September 28, 2017 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract based on the Phase 3 SECURE trial of its...